Summary
Sixteen days after a unilateral lesion of the ventromedial tegmentum (VMT) of the midbrain, adult cats received an intravenous dose of L-DOPA (20 mg/kg), and the caudate nucleus from each hemisphere was removed at various time intervals thereafter. In the caudate nucleus contralateral to the VMT lesions, DA levels reached 200 °/o of control values within 15 min, and maintained this elevation for at least 2 hours. DA levels in the caudate nucleus ipsilateral to the VMT lesion were much lower than contralateral values; however, they were much higher than those of non-DOPA treated animals with comparable lesions. DA levels in the caudate nucleus of the lesioned hemisphere were directly related to the remaining DOPA de- carboxylase activity. The striatal serotonin concentrations were unchanged after L-DOPA, but an increase in 5-hydroxyindoleacetic acid levels was observed. From these results, we conclude that, (i) in cats with nigrostriatal tract lesions after low doses of L-DOPA comparable to those given to patients with Parkinson’s disease, the bulk of the newly formed DA in the caudate nucleus is contained in nigrostriatal neurons, and (ii) there exists an inverse relationship between the ability of the caudate to synthesize DA and the severity of the nigrostriatal tract lesion.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andén, N.-E., Roos, B.-E., Werdinius, B.: On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorimetric method. Life Sciences 2, 448–458 (1968).
Bartholini, G., Pletscher, A.: Cerebral accumulation and metabolism of 14C-L-DOPA after selective inhibition of peripheral decarboxylase. J. Pharmacol. Exp. Ther. 161, 14–20 (1968).
Bartholini, G., Da Prada, M., Pletscher, A.: Decrease of cerebral 5-hydroxy- tryptamine by 3, 4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase. J. Pharm. Pharmac. 20, 219–229 (1968).
Bernheimer, H., Birkmayer, W., Hornykiewicz, O.: Verteilung des 5-Hydroxy-tryptamin (Serotonin) im Gehirn des Menschen und sein Verhalten bei Patienten mit Parkinson-Syndrom. Klin. Wsch. 39, 1056— 1059 (1961).
Bertler, A., Falck, B., Owman, Ch., Rosengren, E.: The localization of monoaminergic blood-brain mechanisms. Pharmacol. Revs. 18, 369–385 (1966).
Bogdanski, D. F., Pletscher, A., Brodie, A., Brodie, B. B., Udenfriend, S.: Identification and assay of Serotonin in brain. J. Pharmacol. Exp. Ther. 117, 82–88 (1956).
Calne, D. B.: Parkinsonism. London: Arnold. 1970.
Carlsson, A., Waldeck, B.: A fluorimetric method for the determination of dopamine (3-hydroxytyramine). Acta Physiol. Scand. 44, 293–298 (1958).
Constantinidis, J., De La Torte, J. C., Tissot, R., Geissbühler, F.: La barriere capillaire pour la L-DOPA dans le cerveau et les differents organes. Psychopharmacologia 15, 75–87 (1969).
Dagirmanjian, R., Laverty, R., Mantegazzini, P., Sharman, D. F., Vogt, M.: Chemical and physiological changes produced by arterial infusion of dihydroxyphenylalanine into one cerebral hemisphere of the cat. J. Neurochem. 10, 117–182 (1963).
Davidson, L., Lloyd, K. G., Dankova, J., Hornykiewicz, O.: L-DOPA treatment in Parkinson’s disease: effect on dopamine and related substances in discrete brain regions. Experientia 27, 1048–1049 (1971).
De La Torre, J.C.: The blood-brain barrier for L-DOPA in the hypo- thalamus. J. Neurol. Sci. 12, 77–93 (1971).
Dowson, J. H.: Animal models for an enzymic blood-brain barrier mechanism for therapeutically administered L-DOPA. Life Sciences 13, 23–29 (1973).
Euler, U. S. Von, Floding, J.: Diagnosis of pheochromocytoma by fluori-metric estimation of adrenaline and noradrenaline in urine. Scand. J. Clin. Lab. Invest. 8, 288–295 (1956).
Everett, G. M., Borcherding, J. W.: L-DOPA: Effect on concentrations of 5-hydroxytryptamine in brains of mice. Science 168, 849–850 (1970).
Goldstein, M., Anagnoste, B., Owen, W. S., Battista, A. F.: The effects of ventromedial tegmental lesions on the disposition of dopamine in the caudate nucleus of the monkey. Brain Research 4, 298–300 (1967).
Goldstein, M., Anagnoste, B., Battista, A. F., Nakatani, S., Ogawa, M.: Biochemical aspects of experimentally induced parkinsonism. Neurotransmitters Res. Publ., A.R.N.M.D. 50, 434–437 (1972).
Heller, A., Bhatnagar, R. K., Moore, R. Y.: Selective neuronal control of telencephalic monoamines and enzymes involved in their biosynthesis. In: Progress in Neurogenetics (Barbeau, A., Brünette, J. R., eds.), pp. 283–288. Amsterdam: Excerpta Medica. 1969.
Hockman, C. H., Lloyd, K. G., Farley, I. G., Hornykiewicz, O.: Experi- mental midbrain lesions: neurochemical comparison between the animal model and Parkinson’s disease. Brain Research 35, 613–618 (1971).
Hornykiewicz, O.: Dopamine (3-hydroxytyramine) and brain funetion. Pharmacol. Rev. 18, 925–962 (1966).
Hornykiewicz, O.: Physiological, biochemical and pathological background of levodopa and possibilities for the future. Neurology 20, 1–5 (1970).
Karobath, M., Diaz, J. L., Huttunen, M. O.: The effect of L-DOPA on the concentrations of tryptophan, tyrosine and Serotonin in rat brain. Europ. J. Pharmacol. 14, 393–396 (1971).
Kuruma, L, Bartholini, G., Pletscher, A.: L-DOPA induced accumulation of 3-O-methyl-DOPA in brain and heart. Europ. J. Pharmacol. 10, 189–192 (1970).
Langelier, P., Parent, A., Poirier, L. J.: Decarboxylase activity of the brain capillary walls and parenehyma in the rat, cat and monkey. Brain Research 45, 622–629 (1972).
Lloyd, K. G., Hornykiewicz, O.: Parkinson’s disease: Activity of L-DOPA decarboxylase in discrete brain regions. Science 170, 1212–1213 (1970).
Lloyd, K. G., Hornykiewicz, O.: Occurrence and distribution of aromatic L-amino acid (L-DOPA) decarboxylase in the human brain. J. Neuro- chem. 19, 1549–1559 (1972).
Lloyd, K. G., Davidson, L., Hornykiewicz, O.: The neurochemistry of Parkinson’s disease: effect of L-DOPA therapy. J. Pharmacol. Exp. Ther. 195, 453–464 (1975).
Lytle, L. D., Hurko, D., Romero, J. A., Cottman, K., Leehey, D., Wurtman, R. J.: The effects of 6-hydroxydopamine pretreatment on the accumulation of DOPA and dopamine in brain and peripheral organs following L-DOPA administration. J. Neural Transm. 33, 63–71 (1972).
Owman, Ch., Rosengren, E.: Dopamine formation in brain capillaries and enzymic blood-brain barrier mechanism. J. Neurochem. 14, 547–550 (1967).
Nagatsu, T., Yamamoto, T.: Fluorescence assay of tyrosine hydroxylase activity in tissue homogenate. Experientia 24, 1183–1184 (1968).
Poirier, L. L., Sourkes, T. L.: Influence of the substantia nigra on the catecholamine content of the striatum. Brain 88, 181–192 (1965).
Poirier, L. J., Singh, P., Sourkes, T. L., Boucher, R.: Effect of amines pre- cursors on the concentration of striatal dopamine and Serotonin in cats with and without unilateral brainstem. Brain Research 6, 954–966 (1967).
Rinne, U. K., Sonninen, V.: Brain catecholamines and their metabolites in parkinsonian patients. Arch. Neurol. 28, 107–110 (1972).
Rinne, U. K., Sonninen, V., Hyyppa, M.: Effect of L-DOPA on brain monoamines and their metabolites in Parkinson’s disease. Life Sciences I, 10, 549–557 (1971).
Rinne, U. K., Sonninen, V., Rickkinen, P., Laaksonen, H.: Dopaminergic nervous transmission in Parkinson’s disease. Med. Biol. 52, 208–217 (1974).
Scapagnini, U., Vandenbroeck, R., Schaepdryver, A. D. de: Simultaneous estimation of 5-hydroxytryptamine and 5-hydroxy-indole-3-acetic acid in rat brain. Biochem. Pharmacol. 18, 938–940 (1969).
Schaepdryver, A. D. de: Differential fluorimetric estimation of adrenaline and noradrenaline in urine. Arch. Int. Pharmacodyn. 115, 233–245 (1958).
Snider, R. S., Niemer, W. T.: A stereotaxic atlas of the cat brain. Chicago: Univ. of Chicago Press. 1960.
Ungerstedt, U.: 6-Hydroxydopamine induced degeneration of central mono- amine neurons. Europ. J. Pharmacol. 5, 107–110 (1968).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag
About this chapter
Cite this chapter
Lloyd, K.G., Hockmann, C.H., Davidson, L., Farley, I.J., Hornykiewicz, O. (1980). Kinetics of L-DOPA Metabolism in the Caudate Nucleus of Cats with Ventrotegmental Lesions. In: Carlsson, A., Jellinger, K., Riederer, P. (eds) Current Topics in Extrapyramidal Disorders. Journal of Neural Transmission, vol 16. Springer, Vienna. https://doi.org/10.1007/978-3-7091-8582-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-7091-8582-7_5
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-8584-1
Online ISBN: 978-3-7091-8582-7
eBook Packages: Springer Book Archive